Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 85051-85100 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT06048926
Carrelizumab Combined With Concurrent Radiotherapy and Chemotherapy for Unresectable Esophageal Squamous Cell Carcinoma
NA
Enrolling by invitation
30 participants
Started: Jul 30, 2022 · Completed: Jul 30, 2028
1 condition
1 sponsor
1 location
NCT05455307
Efficacy and Safety of Allium Ureteral Stent for Treating Refractory Ureteral Stricture
NA
Recruiting
200 participants
Started: Jul 30, 2022 · Completed: Jul 30, 2027
3 conditions
1 sponsor
1 location
NCT05397587
An Immunity Persistence Study of Enterovirus 71 Inactivated Vaccine (Vero Cell)
PHASE4
Not yet recruiting
474 participants
Started: Jul 30, 2022 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT05448066
Molecular Allergen Component Resolved Diagnosis to Decide Immunotherapy
NA
Recruiting
210 participants
Started: Jul 30, 2022 · Completed: Jun 30, 2026
2 conditions
2 sponsors
1 location
NCT05417750
A Phase I Study on Autologous Tumor Infiltrating Lymphocytes Injection (GC101 TIL) for the Treatment of Advanced Malignant Solid Tumors
PHASE1
Recruiting
60 participants
Started: Jul 30, 2022 · Completed: Apr 30, 2026
6 conditions
1 sponsor
1 location
NCT05303467
A Feasibility Study to Evaluate the Safety of the TheraSphere Glioblastoma (GBM) Device in Patients With Recurrent GBM
PHASE1
Recruiting
36 participants
Started: Jul 30, 2022 · Completed: Jun 1, 2026
2 conditions
1 sponsor
9 locations
NCT05459948
The Medacta GMK SpheriKA Post-Marketing Surveillance Study
N/A
Recruiting
281 participants
Started: Jul 30, 2022 · Completed: May 31, 2035
2 conditions
1 sponsor
4 locations
NCT05033756
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients With Unresectable or Metastatic HER2 Negative Breast Cancer and a Deleterious Germline Mutation or a Homologous Recombination Deficiency (COMPRENDO
PHASE2
Active, not recruiting
11 participants
Started: Jul 30, 2022 · Completed: Feb 28, 2026
2 conditions
2 sponsors
6 locations
NCT05811845
Mercaptopurine Therapeutic Drug Monitoring to Optimize the Maintenance Phase of Childhood ALL
N/A
Recruiting
250 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
4 locations
NCT05707819
Sintilimab in Combination With Chemoradiotherapy in High-risk Locoregionally-advanced Nasopharyngeal Carcinoma
N/A
Recruiting
43 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2028
2 conditions
1 sponsor
1 location
NCT05002478
Infants with Severe Acute Respiratory Distress Syndrome: the Prone Trial
NA
Recruiting
14 participants
Started: Jul 30, 2022 · Completed: Dec 31, 2026
3 conditions
1 sponsor
1 location
NCT05124236
Trial of Preoperative Radiosurgery Versus Postoperative Stereotactic Radiotherapy for Resectable Brain Metastases
NA
Recruiting
200 participants
Started: Jul 29, 2022 · Completed: Dec 30, 2025
1 condition
2 sponsors
8 locations
NCT06154902
Real-World Outcomes in Relapsed/Refractory Multiple Myeloma Patients Treated, or Eligible for Treatment, With Idecabtagene Vicleucel
N/A
Active, not recruiting
350 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2027
1 condition
1 sponsor
1 location
NCT05394766
Remote Patient Monitoring and Health Coaching vs. Usual Care for the Treatment of Hypertension
NA
Recruiting
550 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition
2 sponsors
1 location
NCT05595473
A Study to Evaluate the Safety, Tolerability and Efficacy of RZ-001 with Valganciclovir (VGCV) in Subjects with Hepatocellular Carcinoma
PHASE1/PHASE2
Active, not recruiting
42 participants
Started: Jul 29, 2022 · Completed: May 31, 2029
1 condition
1 sponsor
5 locations
NCT06488209
Single and Multiple Ascending Dose Study in Healthy Participants and Participants With an Autoimmune Disease
PHASE1
Recruiting
72 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
2 conditions
1 sponsor
3 locations
NCT05363046
Noninterventional Study Evaluating Parkinson's Disease Diary Use
N/A
Active, not recruiting
194 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2026
1 condition
1 sponsor
34 locations
NCT06978985
Adult SMA Research and Clinical Hub
N/A
Recruiting
600 participants
Started: Jul 29, 2022 · Completed: Apr 30, 2027
1 condition
5 sponsors
18 locations
NCT05379595
A Study of Amivantamab Monotherapy and in Addition to Standard-of-Care Chemotherapy in Participants With Advanced or Metastatic Colorectal Cancer
PHASE1/PHASE2
Recruiting
225 participants
Started: Jul 29, 2022 · Completed: Oct 31, 2031
1 condition
1 sponsor
53 locations
NCT05240014
Enhancing Voluntary Motion in Broad Patient Populations With Modular Powered Orthoses
NA
Recruiting
33 participants
Started: Jul 29, 2022 · Completed: Sep 21, 2026
3 conditions
2 sponsors
1 location
NCT04959695
Evaluation of the PE Coach Mobile Application Among Veterans With PTSD
NA
Recruiting
124 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2027
1 condition
2 sponsors
1 location
NCT06108999
Management of Acute and Chronic Wounds With Hyaluronic Acid
NA
Recruiting
170 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2024
2 conditions
1 sponsor
3 locations
NCT06868771
Study on the Effectiveness of an Emollient Cream Containing Pre and Postbiotic and Niacinamide 4% in the Treatment of Skin Xerosis and Itching in Oncological Patients Treated with Anti-EGFR
NA
Recruiting
164 participants
Started: Jul 29, 2022 · Completed: Apr 30, 2025
1 condition
1 sponsor
1 location
NCT05222984
Navitoclax, Venetoclax, and Decitabine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia Previously Treated With Venetoclax
PHASE1
Active, not recruiting
17 participants
Started: Jul 29, 2022 · Completed: Apr 2, 2026
2 conditions
2 sponsors
1 location
NCT06758271
Special Drug Use-results Survey for Long-term Use(Avacopan)
N/A
Recruiting
250 participants
Started: Jul 29, 2022 · Completed: May 31, 2028
2 conditions
1 sponsor
1 location
NCT05727163
FOLFOX Via HAI Plus Intravenous Irinotecan With or Without Bevacizumab Versus Systemic FOLFOXIRI With or Without Bevacizumab in Initially Unresectable RAS-mutated CRLM Patients
PHASE2
Recruiting
194 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT05288985
Impact of Loco-regional Analgesia Following Placement of Erector Spinae Plane Catheter in Addition to Systemic Analgesia in Patients With Thoracic Trauma
NA
Recruiting
40 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
1 location
NCT05489783
Glioma Developmental and HyperActive Ras Tumor (DHART) Board
N/A
Recruiting
50 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2026
1 condition
1 sponsor
7 locations
NCT05389215
Clinical Trial to Evaluate the Safety and Efficacy of DWN12088 in Patients With IPF
PHASE2
Recruiting
102 participants
Started: Jul 29, 2022 · Completed: Jan 30, 2027
1 condition
1 sponsor
30 locations
NCT05457257
Clinical Study to Assess the Efficacy and Safety of Olaparib in Chinese Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Failed Prior Treatment With a New Hormonal Agent and Have BRCA1/2 Mutations
PHASE4
Active, not recruiting
43 participants
Started: Jul 29, 2022 · Completed: Sep 30, 2025
1 condition
4 sponsors
35 locations
NCT06589869
Effect of High-Intensity Focused Electromagnetic (HIFEM) Technology in the Treatment of SUI in Chinese Men Undergone Robotic Radical Prostatectomy
NA
Recruiting
184 participants
Started: Jul 29, 2022 · Completed: Jun 30, 2026
2 conditions
1 sponsor
1 location
NCT05451901
Immediate Necrosectomy vs. Step-up Approach for Walled-off Necrosis
NA
Recruiting
70 participants
Started: Jul 29, 2022 · Completed: Apr 11, 2031
4 conditions
1 sponsor
21 locations
NCT05384769
Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
NA
Recruiting
108 participants
Started: Jul 29, 2022 · Completed: Jan 28, 2029
1 condition
2 sponsors
1 location
NCT05459090
Functional Study of Inhibitory Neurotransmission in the Human Epileptic Brain.
N/A
Recruiting
60 participants
Started: Jul 29, 2022 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT05420844
Pilot Study to Evaluate a Voice Journaling Application in Adolescents With Cystic Fibrosis
NA
Active, not recruiting
30 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2024
1 condition
1 sponsor
1 location
NCT05221931
Drug-Coated Balloon in Patients With High Bleeding Risk
NA
Recruiting
1,350 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2028
1 condition
17 sponsors
17 locations
NCT06899789
Long-term Follow-up of Checkpoint Inhibitors-induced Ileo-colitis
N/A
Recruiting
250 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
4 conditions
1 sponsor
1 location
NCT05402579
Diabetic Ketoacidosis From New SGLT2i: Can Genomics Estimate Risk
N/A
Recruiting
60 participants
Started: Jul 29, 2022 · Completed: Feb 1, 2025
3 conditions
4 sponsors
2 locations
NCT05500755
Clinical and Radiographic Evaluation of Dentsply Sirona PrimeTaper Implants
N/A
Recruiting
150 participants
Started: Jul 29, 2022 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT03999853
Butyrate Adjuvant Therapy for Type 1 Diabetes
PHASE1/PHASE2
Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition
3 sponsors
1 location
NCT05118477
vHDU Phase 5: Impact of an Ambulatory Monitoring System on Deterioration Detection and Clinical Outcomes
NA
Recruiting
120 participants
Started: Jul 28, 2022 · Completed: Mar 31, 2025
2 conditions
2 sponsors
1 location
NCT06272292
Biomechanical Investigation of Symptomatic FAI and Two Groups of Asymptomatic Controls
NA
Recruiting
99 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05462587
A Study to Evaluate Efficacy and Safety of AVTX-803 in Patients with Leukocyte Adhesion Deficiency Type II
PHASE3
Recruiting
4 participants
Started: Jul 28, 2022 · Completed: Nov 30, 2024
1 condition
1 sponsor
1 location
NCT05475262
Sleepless at Scripps: An Inpatient White Noise Study
NA
Recruiting
50 participants
Started: Jul 28, 2022 · Completed: Feb 1, 2027
4 conditions
1 sponsor
1 location
NCT05167409
A Study of Evorpacept (ALX148) With Cetuximab and Pembrolizumab for Refractory Microsatellite Stable Metastatic Colorectal Cancer
PHASE2
Active, not recruiting
48 participants
Started: Jul 28, 2022 · Completed: Mar 1, 2026
1 condition
6 sponsors
4 locations
NCT04929951
The Effect of Micro Fragmented Adipose Tissue (MFAT) on Shoulder Osteoarthritis
PHASE1
Recruiting
48 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05285878
Fingolimod for the Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation
PHASE2
Enrolling by invitation
20 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2027
7 conditions
1 sponsor
1 location
NCT05024760
Antiseptic Effects on the Dental Implant Internal Surface Microbiome
EARLY_PHASE1
Recruiting
150 participants
Started: Jul 28, 2022 · Completed: Nov 30, 2025
4 conditions
2 sponsors
1 location
NCT05825508
PedBot Ankle Rehablitation
N/A
Active, not recruiting
20 participants
Started: Jul 28, 2022 · Completed: Jul 28, 2025
1 condition
1 sponsor
1 location
NCT05312983
Development of a Battery of Audiological Tests for the Precision Diagnosis of Age-related Hearing Loss
NA
Recruiting
700 participants
Started: Jul 28, 2022 · Completed: Dec 31, 2030
1 condition
3 sponsors
2 locations
Previous
1
More pages
1699
1700
1701
1702
1703
1704
1705
More pages
2369
Next